Alan J. Tuchman's most recent trade in Synaptogenix Inc was a trade of 4,315 Common Stock, par value $0.0001 per share done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Synaptogenix Inc | Alan J. Tuchman | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 4,315 | 5,635 | - | 0 | Common Stock, par value $0.0001 per share | |
| Synaptogenix Inc | Alan J. Tuchman | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.85 per share. | 30 Jun 2025 | 1,726 | 3,909 | - | 7.8 | 13,549 | Common Stock, par value $0.0001 per share |
| Synaptogenix Inc | Alan J. Tuchman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 27,000 | 33,000 | - | 1.2 | 31,641 | Common Stock, par value $0.0001 per share |
| Synaptogenix Inc | Alan J. Tuchman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 68,850 | 68,850 | - | - | Stock Option (Right to Buy) | |
| Synaptogenix Inc | Alan J. Tuchman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 6,150 | 6,150 | - | - | Stock Option (Right to Buy) | |
| Synaptogenix Inc | Alan J. Tuchman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 60,000 | 60,000 | - | 0 | Common Stock, par value $0.0001 per share |